Active, not recruitingNot applicableNCT03113981

Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)

Studying Osteonecrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Societe ACTIVBIOMAT
Principal Investigator
Thomas Bauer, MD, PhD
Hospital Ambroise Paré Paris
Intervention
Total Hip Arthroplasty(device)
Enrollment
340 target
Eligibility
18-74 years · All sexes
Timeline
20172039

Study locations (7)

Collaborators

Slb Pharma

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03113981 on ClinicalTrials.gov

Other trials for Osteonecrosis

Additional recruiting or active studies for the same condition.

See all trials for Osteonecrosis

← Back to all trials